Open AccessNervous system damage in COVID-19 with an emphasis on the management of patients with multiple sclerosis
Author(s) -
Alexey Boyko,
С А Сиверцева,
Н Н Спирин
Publication year - 2020
Publication title -
nevrologiâ, nejropsihiatriâ, psihosomatika
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.157
H-Index - 9
eISSN - 2310-1342
pISSN - 2074-2711
DOI - 10.14412/2074-2711-2020-1s-44-47
Subject(s) - multiple sclerosis , medicine , central nervous system , coronavirus , covid-19 , nervous system , pandemic , encephalitis , magnetic resonance imaging , virus , pathology , immunology , disease , infectious disease (medical specialty) , psychiatry , radiology
The main target for COVID-19 is the lung with the development of acute respiratory failure. But the virus also displays tropism to the central nervous, muscle, and immune systems. The paper gives the data available in the literature on nervous system damage and the characteristics of clinical and magnetic resonance imaging manifestations of brain damage in COVID-19. Among the neurological symptoms of COVID-19, there may be stroke, encephalitis, and neuropathy. An account is given of the features of multiple sclerosis patient management during the COVID-19 pandemic depending on the risk of developing coronavirus infection.